159 related articles for article (PubMed ID: 22441548)
21. Implications of prognostic markers in brain tumors.
Grzybicki DM; Moore SA
Clin Lab Med; 1999 Dec; 19(4):833-47. PubMed ID: 10572718
[TBL] [Abstract][Full Text] [Related]
22. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
23. Serum GFAP is a diagnostic marker for glioblastoma multiforme.
Jung CS; Foerch C; Schänzer A; Heck A; Plate KH; Seifert V; Steinmetz H; Raabe A; Sitzer M
Brain; 2007 Dec; 130(Pt 12):3336-41. PubMed ID: 17998256
[TBL] [Abstract][Full Text] [Related]
24. Adult cerebellar glioblastoma cases have different characteristics from supratentorial glioblastoma.
Utsuki S; Oka H; Miyajima Y; Kijima C; Yasui Y; Fujii K
Brain Tumor Pathol; 2012 Apr; 29(2):87-95. PubMed ID: 22076316
[TBL] [Abstract][Full Text] [Related]
25. Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome.
Miyazaki T; Ishikawa E; Matsuda M; Akutsu H; Osuka S; Sakamoto N; Takano S; Yamamoto T; Tsuboi K; Matsumura A
J Neurooncol; 2017 Jun; 133(2):277-285. PubMed ID: 28447277
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of annexin VII expression in glioblastomas multiforme in humans.
Hung KS; Howng SL
J Neurosurg; 2003 Nov; 99(5):886-92. PubMed ID: 14609169
[TBL] [Abstract][Full Text] [Related]
27. Expression of cyclooxygenase-2 and epidermal growth factor receptor in primary and recurrent glioblastoma multiforme.
Sminia P; Stoter TR; van der Valk P; Elkhuizen PH; Tadema TM; Kuipers GK; Vandertop WP; Lafleur MV; Slotman BJ
J Cancer Res Clin Oncol; 2005 Oct; 131(10):653-61. PubMed ID: 16133570
[TBL] [Abstract][Full Text] [Related]
28. Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain.
Geisenberger C; Mock A; Warta R; Rapp C; Schwager C; Korshunov A; Nied AK; Capper D; Brors B; Jungk C; Jones D; Collins VP; Ichimura K; Bäcklund LM; Schnabel E; Mittelbron M; Lahrmann B; Zheng S; Verhaak RG; Grabe N; Pfister SM; Hartmann C; von Deimling A; Debus J; Unterberg A; Abdollahi A; Herold-Mende C
Acta Neuropathol; 2015 Sep; 130(3):419-34. PubMed ID: 25931051
[TBL] [Abstract][Full Text] [Related]
29. Predictors of long-term survival in patients with glioblastoma multiforme: advancements from the last quarter century.
Chaudhry NS; Shah AH; Ferraro N; Snelling BM; Bregy A; Madhavan K; Komotar RJ
Cancer Invest; 2013 Jun; 31(5):287-308. PubMed ID: 23614654
[TBL] [Abstract][Full Text] [Related]
30. Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma.
Mandel JJ; Cachia D; Liu D; Wilson C; Aldape K; Fuller G; de Groot JF
J Neurooncol; 2016 Aug; 129(1):147-54. PubMed ID: 27270908
[TBL] [Abstract][Full Text] [Related]
31. [A clinical and molecular study of long-term survival glioblastomas].
Wang X; Liu YH; Xie F; You C; Mao Q
Zhonghua Wai Ke Za Zhi; 2013 Feb; 51(2):166-70. PubMed ID: 23711013
[TBL] [Abstract][Full Text] [Related]
32. Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.
Li R; Li H; Yan W; Yang P; Bao Z; Zhang C; Jiang T; You Y
Oncotarget; 2015 Mar; 6(9):7318-24. PubMed ID: 25821160
[TBL] [Abstract][Full Text] [Related]
33. Massive dissemination of adult glioblastomas.
Willard N; Kleinschmidt-DeMasters BK
Clin Neuropathol; 2015; 34(6):330-42. PubMed ID: 26308254
[TBL] [Abstract][Full Text] [Related]
34. Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival.
Rahbar A; Orrego A; Peredo I; Dzabic M; Wolmer-Solberg N; Strååt K; Stragliotto G; Söderberg-Nauclér C
J Clin Virol; 2013 May; 57(1):36-42. PubMed ID: 23391370
[TBL] [Abstract][Full Text] [Related]
35. Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastoma.
Seyve A; Lozano-Sanchez F; Thomas A; Mathon B; Tran S; Mokhtari K; Giry M; Marie Y; Capelle L; Peyre M; Carpentier A; Feuvret L; Sanson M; Hoang-Xuan K; Honnorat J; Delattre JY; Ducray F; Idbaih A
Clin Neurol Neurosurg; 2020 Sep; 196():106006. PubMed ID: 32554237
[TBL] [Abstract][Full Text] [Related]
36. A longer time to relapse is associated with a larger increase in differences between paired primary and recurrent IDH wild-type glioblastomas at both the transcriptomic and genomic levels.
Ho WM; Chen CY; Chiang TW; Chuang TJ
Acta Neuropathol Commun; 2024 May; 12(1):77. PubMed ID: 38762464
[TBL] [Abstract][Full Text] [Related]
37. The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma.
Liu X; Mangla R; Tian W; Qiu X; Li D; Walter KA; Ekholm S; Johnson MD
J Neurooncol; 2017 Dec; 135(3):553-560. PubMed ID: 28889246
[TBL] [Abstract][Full Text] [Related]
38. A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools.
Thuy MN; Kam JK; Lee GC; Tao PL; Ling DQ; Cheng M; Goh SK; Papachristos AJ; Shukla L; Wall KL; Smoll NR; Jones JJ; Gikenye N; Soh B; Moffat B; Johnson N; Drummond KJ
J Clin Neurosci; 2015 May; 22(5):785-99. PubMed ID: 25698544
[TBL] [Abstract][Full Text] [Related]
39. H3K27M, IDH1, and ATRX expression in pediatric GBM and their clinical and prognostic significance.
Uppar AM; Sugur H; Prabhuraj AR; Rao MB; Devi BI; Sampath S; Arivazhagan A; Santosh V
Childs Nerv Syst; 2019 Sep; 35(9):1537-1545. PubMed ID: 31152217
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics and neuroimaging findings in 12 cases of recurrent glioblastoma with communicating hydrocephalus.
Onuma K; Ishikawa E; Matsuda M; Hirata K; Osuka S; Yamamoto T; Masumoto T; Zaboronok A; Matsumura A
Neurol Med Chir (Tokyo); 2013; 53(7):474-81. PubMed ID: 23883558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]